What is Arcutis Biotherapeutics, Inc.'s total cost of revenue?

Arcutis Biotherapeutics, Inc. (ARQT) reported total cost of revenue of $9.78M in Q1 2026.

How has Arcutis Biotherapeutics, Inc.'s total cost of revenue changed year-over-year?

Arcutis Biotherapeutics, Inc.'s total cost of revenue increased by 10.8% year-over-year, from $8.83M to $9.78M.

What does total cost of revenue mean?

The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

Arcutis Biotherapeutics, Inc. ARQT Total Cost of Revenue

Total Cost of Revenue at other companies

PfizerPFE

$3.55B+24.7%

AmgenAMGN

$2.74B-7.5%

IncyteINCY

$104.52M+42.8%

OrganonOGN

$677M+0.7%

Kiniksa Pharmaceuticals International, plcKNSA

$20.8M+16.4%

LQD

Liquidia CorporationLQDA

$1.52M+3.4%

Segments

By segment

See full

Reportable Segment$9.22M+57.6%

Other financials

Income statement

See full

Revenue$105.4M+60.1%

Gross profit$95.6M+67.7%

Operating income-$9.1M+62.9%

Net income-$11.3M+54.9%

EPS (diluted)-$0.09+55.0%

Balance sheet

See full

Cash & equivalents$35.1M-34.7%

Total debt$114.7M+3.5%

Total equity$189.6M+32.9%

Total assets$460.0M+33.7%

Cash flow

See full

Operating cash flow$2.2M+107%

CapEx--100%

Free cash flow$2.2M+107%

Valuation

See full

Market cap$3.28B+57.5%

Enterprise value$3.36B+57.0%

P/S7.9×-1.9×

Profitability

See full

Gross margin90.9%+2.5pp

Operating margin-12%-5.7pp

Net margin-13.9%-6.6pp

FCF margin-52.5%-21.9pp

Returns & leverage

See full

Return on equity-28.2%-13.0pp

Debt / equity0.6×-0.2×

Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s total cost of revenue?: Arcutis Biotherapeutics, Inc. (ARQT) reported total cost of revenue of $9.78M in Q1 2026.
How has Arcutis Biotherapeutics, Inc.'s total cost of revenue changed year-over-year?: Arcutis Biotherapeutics, Inc.'s total cost of revenue increased by 10.8% year-over-year, from $8.83M to $9.78M.
What does total cost of revenue mean?: The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.